or search on
|Title:||The role of mindfulness in distress and quality of life for men with advanced prostate cancer.|
|Authors:||Chambers SK; Foley E; Clutton S; McDowall R; Occhipinti S; Berry M; Stockler M; Lepore SJ; Frydenberg M; Gardiner RA; Smith DP; Davis ID|
|Categories:||Cancer Type - Prostate Cancer|
Treatment - Complementary and Alternative Treatment Approaches
|Journal Title:||Quality of Life Research|
|Page number start:||3027|
|Page number end:||3035|
|Abstract:||OBJECTIVE: To examine the extent to which mindfulness skills influence psychological distress and health-related quality of life (HRQOL) in men with metastatic or castration-resistant biochemical progression of prostate cancer. PATIENTS AND METHODS: A cross-sectional survey of 190 men (46 % response; mean age 71 years, SD = 8.7, range 40-91 years) with advanced prostate cancer, assessed psychological and cancer-specific distress, HRQOL. Mindfulness skills were assessed as potential predictors of adjustment outcomes. RESULTS: Overall, 39 % of men reported high psychological distress. One third had accessed psychological support previously although only 10 % were under current psychological care. One quarter had accessed a prostate cancer support group in the past six months. Higher HRQOL and lower cancer-specific and global psychological distress were related to non-judging of inner experience (p < 0.001). Higher HRQOL and lower psychological distress were related to acting with awareness (p < 0.001). Lower distress was also related to higher non-reactivity to inner experience and a lower level of observing (p < 0.05). CONCLUSIONS: Men with advanced prostate cancer are at risk of poor psychological outcomes. Psychological flexibility may be a promising target for interventions to improve adjustment outcomes in this patient group.|
|Division:||Cancer Research Division|
|Funding Body:||This project was a collaboration between Cancer Council Queensland, Griffith University and the Australian and New Zealand Uro-genital and Prostate (ANZUP) Cancer Trials Group that was funded by an Australian National Health and Medical Research Council Project Grant (ID: APP1024989). SKC had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The sponsors did not participate in the design or conduct of the study; collection, management, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript. SKC is an Australian Research Council Future Fellow. IDD is supported by an NHMRC Practitioner Fellowship. DS was supported by a grant from Cancer Institute NSW (#15/CDF/1-10).|
|Appears in Collections:||Research Articles|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.